ClinicalTrials.gg
RecruitingNCT07071116Updated Jul 13, 2026

Seminar in Unwavering Empowering Presence Optimized for Rehabilitation Teams

An interventional study of Communication skills training and Communication skills training-Facilitator in Communication, sponsored by St. Jude Children's Research Hospital. Recruiting at 1 site in United States. Per ClinicalTrials.gov, last updated 2026-07-13.

Sponsored by St. Jude Children's Research Hospital · Not applicable, Interventional, and Other

From the registry’s dates

  • Started Jul 2025; still recruiting 1 year 4 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
25
Allocation
Non-randomized
Sex
All
01

Study summary

The goal of this study to test the feasibility, acceptability, and potential impact of a serious illness communication skills training (CST) tailored to rehabilitation professionals to improve their comfort and confidence in navigating difficult conversations with patients and families.

Primary Objectives:

Aim 1: To assess feasibility and acceptability of a multidisciplinary co-designed interactive CST program for rehabilitation professionals who care for children with serious illness and their families.

Aim 2: To characterize the potential impact of this CST intervention on pediatric rehabilitation professionals.

Secondary Objective:

Aim 3: To examine the perspectives of bereaved parent educators on participation in the implementation of communication training for rehabilitation professionals.

Read the detailed description

The Communication Skills training (CST) will last approximately 3 hours. It will consist of three main components: Part 1 will begin with an introductory case of an emotional parent, then a brief didactic with a framework on responding to emotion, and end with rehab professionals actively practicing 'drills' using the framework for responding to emotion. Part 2 will be a panel of bereaved parents. Learners will be asked to think of questions to ask the parents in advance and will also be invited to ask questions that come to mind in the moment. Part 3 will be focused on sharing serious news, beginning with an introductory case of sharing cancer progression, followed by didactic teaching in a VitalTalk framework, 'REMAP,' for sharing serious news and eliciting goals/values. Leaders will then introduce role-play via a demonstration case. Next, learners will be divided into small groups for discussion and role-play, with a strong emphasis on principles of psychological safety and learner autonomy. and incorporates didactic instruction, experiential learning, and involvement of bereaved parent educators.

Demographic information will be collected for participating bereaved parent educators and rehabilitation professionals. Rehabilitation professionals will complete pre-intervention self-assessment surveys immediately prior to the educational intervention. Post-intervention self-assessment surveys will be administered immediately after completion of the intervention and 3-months post-intervention to assess for retention. Rehabilitation professionals and bereaved parent educators will also be interviewed about their experience following the intervention. The interviews will be done on an individual basis either virtually or in-person.

02

Conditions studied

  • Communication

Browse trials for

Keywords

  • Communication Skills Training (CST)
  • Rehabilitation Professionals
03

In context

Communication

719 studies on the registry are indexed under Communication; 159 are open to participants now.

This study's planned enrollment of 25 is below the median of 144 across 571 interventional studies indexed under Communication.

Browse Communication studies →

Lead sponsor

St. Jude Children's Research Hospital is the lead sponsor of 440 studies on the registry; 102 are open to participants now.

Of its 61 completed or terminated interventional studies of FDA-regulated products, 37 (61%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
All
Accepts healthy volunteers
Yes

Eligibility criteria

Inclusion Criteria: Intervention Participants

  • Licensed rehabilitation professionals (e.g., physical therapists, occupational therapists, speech-language pathologists) employed at St. Jude Children's Research Hospital actively involved in the care of pediatric oncology patients.
  • Willingness to participate in the communication skills training (CST) intervention and associated study activities.

Inclusion Criteria: Intervention Facilitators

  • St. Jude Bereaved Parent Educators who have participated as an educator in at least one other institutional educational event
  • Willingness to facilitate the communication skills training (CST) intervention and complete associated study activities.

Exclusion Criteria: Intervention Participants

  • Non-rehabilitation professionals
  • Individuals unable to attend the CST intervention session.

Exclusion Criteria: Intervention Facilitators

  • Individuals unable to attend the CST intervention session.
05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Non-randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
25 participants (estimated)

Study arms

  • Other
    Licensed rehabilitation professionals

    Licensed rehabilitation professionals (e.g., physical therapists, occupational therapists, speech-language pathologists) employed at St. Jude Children's Research Hospital actively involved in the care of pediatric oncology patients who will participate in the CST intervention

    Other: Communication skills training

  • Other
    St. Jude Bereaved Parent Educators

    St. Jude Bereaved Parent Educators who have participated as an educator in at least one other institutional educational event and will facilitate the CST intervention

    Other: Communication skills training-Facilitator

Interventions

  • OtherCommunication skills training

    See Detailed Description

    Also known as: CST

  • OtherCommunication skills training-Facilitator

    See Detailed Description

    Also known as: CST-Facilitator

06

What researchers measure

Primary outcomes

  1. Proportion of participants who achieve a mean score ≥3 on the Feasibility of Intervention Measure (FIM) scale

    Investigators will compute the mean Feasibility of Intervention Measure (FIM) score for each participant using the Feasibility of Intervention Measure (FIM) and report the proportion of participants who achieve a mean score ≥3. The Feasibility of Intervention Measure (FIM) is used to assess how feasible it is to implement a specific intervention. The FIM measure includes four itemized responses that are scored from one to five (1=Completely disagree, 2=Disagree, 3=Neither agree nor disagree, 4=Agree, 5=Completely agree) such that one represents the lowest possible mean score and five the highest possible mean score. It is scored by averaging the responses to each of the four questions. Higher scores indicate greater perceived feasibility of the intervention.

    Time frame: Approximately 3 months post intervention

  2. Proportion of participants who achieve a mean score ≥3 on Acceptability of Intervention Measure (AIM) scale

    Investigators will compute the mean Acceptability of Intervention Measure (AIM) score for each participant and report the proportion of participants who achieve a mean score ≥3. The Acceptability of Intervention Measure (AIM) is a four-item scale used to assess the acceptability of an intervention. It is scored by calculating the mean of the responses to its four items, each measured on a 5-point Likert scale(1=Completely disagree, 2=Disagree, 3=Neither agree nor disagree, 4=Agree, 5=Completely agree). This results in a final score ranging from 1 to 5, with higher scores indicating greater acceptability.

    Time frame: Approximately 3 months post intervention

  3. Proportion of participants who achieve a mean score ≥3 on the Intervention Appropriateness Measure (IAM) scale

    Investigators will compute the mean Intervention Appropriateness Measure (IAM) score for each participant and report the proportion of participants who achieve a mean score ≥3. The Intervention Appropriateness Measure (IAM) is a four-item scale used to assess the appropriateness of interventions by capturing individual perspectives on the alignment of the intervention with professional values and perceived efficacy in meeting patient needs. Each item is rated on a 5-point Likert scale (1=Completely disagree, 2=Disagree, 3=Neither agree nor disagree, 4=Agree, 5=Completely agree). The score is calculated by averaging the responses to all items. A higher score on the IAM indicates a stronger perception that the intervention is appropriate for the given situation and context.

    Time frame: Approximately 3 months post intervention

  4. Potential impact of this CST intervention on pediatric rehabilitation professionals

    Investigators will calculate the proportions of participants who select "Agree" or "Completely agree" in both the pre- and post-intervention surveys and conduct statistical tests, such as Fisher's exact test or the Chi-square test, to determine whether the change in these proportions over time is statistically significant.

    Time frame: Prior to the start of the intervention (day 1) and at the end of study, approximately 3 months

Secondary outcomes

  1. Perspectives of bereaved parent educators on participation in the implementation of communication training for rehabilitation professionals.

    Interviews will be conducted with bereaved parent educators following the intervention. Interviews will be recorded, transcribed, de-identified, and analyzed using content analysis, an inductive approach which may include memo-writing, codebook development, coding, reconciliation, and synthesis to identify patterns and themes that emerge from the interviews.

    Time frame: Within 3 months post intervention

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: Yes — Individual participant de-identified datasets containing the variables analyzed in the published article will be made available (related to the study primary or secondary objectives contained in the publication). Supporting documents such as the protocol, statistical analyses plan, and informed consent are available through the CTG website for the specific study. Data used to generate the published article will be made available at the time of article publication. Investigators who seek access to individual level de-identified data will contact the computing team in the Department of Biostatistics (ClinTrialDataRequest@stjude.org) who will respond to the data request.

Supporting information: Study protocol, Statistical analysis plan, Informed consent form

Time frame: Data will be made available at the time of article publication.

Access criteria: Data will be provided to researchers following a formal request with the following information: full name of requestor, affiliation, data set requested, and timing of when data is needed. As an informational point, the lead statistician and study principal investigator will be informed that primary results datasets have been requested.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jul 13, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07071116
Responsible party
Sponsor
First posted
Jul 17, 2025
Start date
Jul 9, 2025
Primary completion
Jul 2028 (estimated)
Completion
Oct 2028 (estimated)
Last update
Jul 13, 2026

Study contacts

Brittany Cowfer, MD
Contact
referralinfo@stjude.org
888-226-4343
Brittany Cowfer, MD
principal investigator · St. Jude Children's Research Hospital

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion